NCT02129348View on ClinicalTrials.gov

Treatment of Psychosis and Agitation in Alzheimer's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

January 31, 2020

Study Completion Date

January 31, 2020

Conditions
Alzheimer's DiseasePsychosisAgitation
Interventions
DRUG

Lithium

DRUG

Placebo

Trial Locations (4)

10032

New York State Psychiatric Institute, New York

33136

University of Miami Miller School of Medicine, Miami

75235

University of Texas Southwestern Medical Center, Dallas

02478

McLean Hospital, Belmont

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

New York State Psychiatric Institute

OTHER

NCT02129348 - Treatment of Psychosis and Agitation in Alzheimer's Disease | Biotech Hunter | Biotech Hunter